Waystar (WAY) Q3 Results Leave Stock Waiting On Faster Revenue Ramps

Waystar Holdings just reminded investors why healthcare revenue automation attracts premium expectations. The firm delivered Q3 2026 revenue of about US$325.6 million and adjusted EBITDA strength in the mid 40% margin range, yet the stock slipped 1.7% to around US$27.66 on the first full trading day after the release.

That pullback jars with a business that continues to post healthy net income, roughly US$31 million this quarter, and strong unlevered free cash flow. The market focused on softer near term growth optics, while the reported numbers pointed to a company still executing a high margin, cash generative model.

Love Waystar Holding's high margins and strong cash generation, but concerned that softer near-term growth optics could keep the stock under pressure. Compare it with other healthcare and automation plays that combine resilient balance sheets with fundamentals in our list of solid balance sheet and fundamentals stocks (24 results)

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs Q3 2025): US$325.6 million vs. US$268.7 million (up about 21%)
• Net Income (Excl. Extra Items, Q3 2026 vs Q3 2025): US$31.0 million vs. US$30.6 million (roughly flat)
• Basic EPS (Q3 2026 vs Q3 2025): US$0.162 vs. US$0.176 (down about 8%)
• Adjusted EBITDA Margin (Q3 2026 vs Q3 2025): about 43% vs. the mid 40% range a year ago (high 40% area in both periods)

Prefer clean charts instead of a dense wall of earnings commentary and figures? See Waystar Holding's full visual picture, including how its valuation compares with its recent results, in our company report for Waystar Holding.

Waystar’s AI and Platform Story Meets Real Milestones

The bullish story on Waystar Holding hinges on health systems consolidating tools and workflows into its AI powered platform rather than sticking with dozens of point solutions.

"The main thing that has to go right is that health systems continue consolidating fragmented revenue cycle tools and manual processes onto Waystar Holding's AI powered platform to manage rising payer complexity and recoupments."

Q3 results give that claim real footing. The business signed its largest client ever, an East Coast health system with about US$7b in net patient revenue that is replacing more than 20 vendors with Waystar. Net revenue retention at 108% and year to date bookings up 25% support this consolidation and wallet share story.

One Narrative disagrees with today's price. → See where this Narrative says Waystar Holding should trade.

Waystar Bear Case: Strong Bookings, Slower Revenue Ramp

Bears worry that Waystar Holding will book impressive AI deals yet see little near term lift in reported results. The concern centers on long ramp times and slower adoption showing up as softer growth.

"Although management highlights a record implementation backlog and larger million dollar bookings tied to AI agents, the 6 to 18 month ramp time for these contracts means any delays or slower adoption of autonomous revenue cycle tools could leave reported revenue tracking close to current low double digit guidance rather than meaningfully lifting earnings."

Q3 tells a mixed story. Bookings rose 25% and backlog climbed more than 50%, yet Q4 revenue guidance points to roughly 6% growth. Management explicitly tied this drag to timing, mix, and longer Iodine performance ramps, which means the bearish timing worry is playing out in the short run even as demand signals remain strong.

Hunt For Mispriced Cash Engines

Waystar Holding just showed how a strong margin story can still clash with cautious growth expectations. The real opportunity sits in finding stocks that could be undervalued before the market closes the gap.

• Company 1 - 49% below our estimate - turns heavy spending on AI data centers, ad tools, and wearable interfaces into products advertisers already use at meaningful scale.
• Company 2 - 43% below our estimate - sells branch automation gear and managed services that banks adopt as they replace legacy teller setups with cash recycling machines.
• Company 3 - 33% below our estimate - supplies cloud databases and AI infrastructure that long term contracts are tying into multicloud deployments and new software agents.

That is three of the list. See the full list of 34 companies trading below our fair value estimates →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com